Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis

UnknownOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Cystic Fibrosis
Trial Locations (3)

55455

RECRUITING

University of Minnesota - Cystic Fibrosis Center, Minneapolis

84132

RECRUITING

University of Utah, Salt Lake City

90033

RECRUITING

University of Southern California, Los Angeles

All Listed Sponsors
collaborator

University of Southern California

OTHER

collaborator

University of Minnesota

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

Brigham and Women's Hospital

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Amgen

INDUSTRY

collaborator

AstraZeneca

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

collaborator

Johnson & Johnson

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Pfizer

INDUSTRY

collaborator

Critical Path Institute

UNKNOWN

collaborator

Predictive Safety Testing Consortium

UNKNOWN

lead

Foundation for the National Institutes of Health

OTHER